Today’s top gainers include the company Eli Lilly and Company (NYSE:LLY) which is in the industry Drug Manufacturers – Major, gaining -2.02% today. In the last week its performance is 0.45%, and 6.86% for the past quarter. Currently, Eli Lilly and Company, LLY has a target price of 97.5, so today’s gain of -2.02% is a significant step towards its target price. The GAP today is therefore -0.20%.
Eli Lilly and Company (NYSE:LLY), has a market cap of 87777.35, and is based in USA. Insider ownership is at 11.40%, and institutional ownership is 77.10%.
At the current price of 79.52, it has a dividend yield of 2.57%, and its target price is 97.5. This is with a profit margin of 12.00%, and total debt/equity of 0.64. Eli Lilly and Company (NYSE:LLY) has a P/E of 34.28, as well as a forward P/E of 19.44.
With a current EPS of 2.32, and a forecasted EPS growth for next year at 13.96%,Eli Lilly and Company (NYSE:LLY) has had a EPS growth for the past five years at -13.20%. For the next five years EPS growth is projected to be 13.06%.
Performance for the year is -2.88%. Since its IPO date on 6/1/1972, the total performance to date is -3.72%.
Volume today for Eli Lilly and Company (NYSE:LLY), is 4328200, while its average volume is 3603.55. Whilst the total gain today was -2.02%, it did have a day high of -4.49%.
Volatility for this week has been at 1.37%, and 1.33% for the month. The 52-week low for Eli Lilly and Company, LLY has been 18.68%, while the 52-week-high has reached -7.98%.
Looking at its return of investments, which is 9.50%, and its return on assets is 6.90%. Eli Lilly and Company (NYSE:LLY) has an operating margin of 14.60%. With a sales growth of 8.60% quarter over quarter. Bearing in mind that Eli Lilly and Company, LLY is in the sector Healthcare, its long-term debt/equity is 0.59, and has a current ratio of 1.5 and 1.1 for quick ratio.
So what is the value of Eli Lilly and Company? Well its PEG is 2.62, and the P/S is 4.26, along with a P/B of 5.75. Meanwhile it has a p/cash of 22.31.